News

Pharma major Lupin Ltd on Thursday said it has received approval from the US health regulator for its generic version of ...
Lupin gains US FDA approval for Tolvaptan tablets in various dosages, marking a significant entry into the nephrology market.
Sidharth Srinivasan, CEO, Lupin Digital Health, added, "With the rising burden of cardiovascular diseases, improving home-based care is no longer optional--it is essential. These guides ...
Mumbai: Lupin Diagnostics Limited, a wholly owned subsidiary of global pharma major Lupin Limited, has received 100 percent ...